Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myriad Genetics

5.09
+0.17003.46%
Post-market: 5.110.0200+0.39%19:04 EDT
Volume:1.69M
Turnover:8.58M
Market Cap:469.18M
PE:-4.55
High:5.17
Open:4.93
Low:4.93
Close:4.92
Loading ...

Myriad Genetics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Yesterday

Balancing Optimism and Caution: Hold Rating for Myriad Genetics Amid Strategic Shifts and Uncertainties

TIPRANKS
·
05 Jun

Myriad Genetics Announces Launch of FirstGene Prenatal Screen in Large-Scale Clinical Study

Reuters
·
03 Jun

Myriad Genetics shares MRD data from MONSTAR-SCREEN 3 study

TIPRANKS
·
02 Jun

Myriad Genetics Announces Breakthrough Clinical Data on Ultra-Sensitive Precise MRD Test for Detecting Circulating Tumor DNA Across Multiple Cancer Types

Reuters
·
02 Jun

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

StockStory
·
27 May

Myriad Genetics Shares Fall After Downgrade From Scotiabank

MT Newswires Live
·
22 May

Myriad Genetics Cut to Sector Perform From Sector Outperform by Scotiabank

Dow Jones
·
21 May

Scotiabank Downgrades Myriad Genetics to Sector Perform From Sector Outperform, Adjusts Price Target to $6 From $20

MT Newswires Live
·
21 May

Myriad Genetics Inc : Scotiabank Cuts to Sector Perform From Sector Outperform; Cuts Target Price to $6 From $20

THOMSON REUTERS
·
21 May

U.S. RESEARCH ROUNDUP-Levi Strauss, Myriad Genetics, Palo Alto

Reuters
·
21 May

Myriad Genetics Inc : Scotiabank Cuts to Sector Perform From Sector Outperform; Cuts Target Price to $6 From $20

THOMSON REUTERS
·
21 May

Myriad Genetics downgraded to Sector Perform from Outperform at Scotiabank

TIPRANKS
·
21 May

Morgan Stanley Cuts Price Target on Myriad Genetics to $7 From $16, Maintains Equalweight Rating

MT Newswires Live
·
19 May

Myriad Genetics price target lowered to $7 from $16 at Morgan Stanley

TIPRANKS
·
19 May

Myriad Genetics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
16 May

Myriad Genetics Inc. to Participate in BofA Securities 2025 Health Care Conference Fireside Chat

Reuters
·
15 May

Myriad Genetics Shares Drop After Downgrade From Wolfe Research

MT Newswires Live
·
09 May

Myriad Genetics Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
08 May

Wolfe Research Downgrades Myriad Genetics to Peer Perform From Outperform

MT Newswires Live
·
08 May